Pharmacy

Cytori Therapeutics Inc, a bio pharma company, has developed the Celution 800/ CRS System that has received regulatory clearance in Europe. Adipose tissue is introduced into the tissue collection chamber, washed to remove blood and free lipid and then digested with the proprietary enzyme reagent to release the Adipose Derived Regenerative Cells (ADRCs).

The ADRCs are then concentrated by short centrifugation and wash cycles before being mixed with the washed fat graft material (also currently prepared by the physician. The process is controlled through automated sensors and processing algorithms to ensure consistent handling of the tissue and cells. The Celution 800/ CRS System is a complete system that prepares ADRCs for clinical use.

The system provides rapid, automated tissue and cell processing in an optimized reproducible system. Further, the automated tissue and cell processing reduce the manpower requirements. Again, this as a tissue delivery device and allows the surgeon have a greater control of the tissue implantation process.